Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in December: ...
Scientists have found a new treatment for people with asthma and chronic obstructive pulmonary disease (COPD) that may be more effective than current options. Over the past 50 years, treatment options ...
Galderma (SWX:GALD) today announced that full results from the phase III OLYMPIA 1 trial, a 24-week study which evaluated the efficacy and safety of nemolizumab monotherapy in adults with ...
New Ohio law restricts transgender students’ access to school restrooms, 'bathroom bill' sparks outcry Ohio Governor Mike DeWine recently signed the "Protect All Students Act," effectively ...